Lea Jung-Poppe



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in “Summaries of Product Characteristics” (2025) Andrikyan W, Sponfeldner M, Jung-Poppe L, Dürr P, Straubmeier MI, Schuster AK, Weisbach L, et al. Journal article Detection of Elevated Risk for Drug-Related Problems in the Hospital (2024) Jung-Poppe L, Pfistermeister B, Nicolaus H, Roggenhofer A, Altenbuchner A, Andrikyan W, Ströbel A, et al. Journal article Artificial intelligence-powered chatbots in search engines: a cross-sectional study on the quality and risks of drug information for patients (2024) Andrikyan W, Sametinger SM, Kosfeld F, Jung-Poppe L, Fromm M, Maas R, Nicolaus H Journal article Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine Data (2023) Andrikyan W, Jung-Poppe L, Altenbuchner A, Nicolaus HF, Pfistermeister B, Dormann H, Fromm M, Maas R Journal article, Original article Systematic Review of Risk Factors Assessed in Predictive Scoring Tools for Drug-Related Problems in Inpatients (2022) Jung-Poppe L, Nicolaus H, Roggenhofer A, Altenbuchner AM, Dormann H, Pfistermeister B, Maas R Journal article, Review article Clarity, clinical applicability and relevance of absolute contraindications in official 'Summaries of Product Characteristics' (SmPCs) (2022) Andrikyan W, Then M, Dürr P, Jung-Poppe L, Schuster A, Weisbach L, Farker K, et al. Conference contribution Improved, but still limited coding of medication-related problems - application of the new WHO ICD-11 code-set to clinical routine data (2022) Jung-Poppe L, Andrikyan W, Altenbuchner A, Pfistermeister B, Dormann H, Fromm M, Maas R Conference contribution